Media Coverage

Riverside Partners to Score 7.4-Times Return on BioAgilytix

Riverside Partners, a Boston-based private equity firm today announced that its portfolio company, BioAgilytix, a leading provider of large molecule bioanalytical testing services, signed an agreement to be acquired by Cobepa S.A., a privately-held investment company.

Click for full article

Private Equity News logo